Indian Journal of Pharmacology Home 

SHORT COMMUNICATION
[View FULLTEXT] [Download PDF]
Year : 2020  |  Volume : 52  |  Issue : 3  |  Page : 216--221

Co-abuse of alprazolam augments the hepato-renal toxic effects of methylphenidate

Meenu Dutt1, Ravinder Naik Dharavath2, Tanzeer Kaur3, Navpreet Kaur1, Kanwaljit Chopra2, Shweta Sharma1 
1 Forensic Toxicology Lab, Institute of Forensic Sciences and Criminology, Panjab University, Chandigarh, India
2 Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
3 Department of Biophysics, Panjab University, Chandigarh, India

Correspondence Address:
Dr. Shweta Sharma
Institute of Forensic Sciences and Criminology, Panjab University, Chandigarh - 160 014
India

OBJECTIVE: Methylphenidate (MPH) is a first-line treatment option for attention-deficit hyperactive disorder and narcolepsy. MPH is one of the most abused psychostimulants by the adults and young population to stay awake, perform better, or improve concentration. The scanty reports say that the medical users or abusers mostly consider the administration of benzodiazepines to overcome the adverse effects, i.e., mood- and anxiety-related problems associated with MPH chronic abuse. This work aims to study the effect of alprazolam (ALZ) on MPH-associated adverse effects on liver and kidney. MATERIALS AND METHODS: Female Wistar rats (n = 58) were administered with MPH (10, 20, and 40 mg/kg) and ALZ (5, 10, and 20 mg/kg) alone and in combination for 28 days. Bodyweight, feed intake, and water intake were monitored weekly. Parameters related to liver and renal function, oxidative stress, and histopathology were performed to evaluate the toxic impacts on the liver and kidneys. RESULTS: ALZ, along with MPH, increased the serum alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, creatinine, and urea levels. The co-abuse also led to elevated oxidative stress and structural abnormalities in the liver and kidney tissues. CONCLUSION: The co-abuse of ALZ has amplified the hepato-renal toxic effects of MPH. Therefore, it is a significant concern for public safety, and their co-abuse must be restricted and discouraged.


How to cite this article:
Dutt M, Dharavath RN, Kaur T, Kaur N, Chopra K, Sharma S. Co-abuse of alprazolam augments the hepato-renal toxic effects of methylphenidate.Indian J Pharmacol 2020;52:216-221


How to cite this URL:
Dutt M, Dharavath RN, Kaur T, Kaur N, Chopra K, Sharma S. Co-abuse of alprazolam augments the hepato-renal toxic effects of methylphenidate. Indian J Pharmacol [serial online] 2020 [cited 2022 May 28 ];52:216-221
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2020;volume=52;issue=3;spage=216;epage=221;aulast=Dutt;type=0